LEXARIA BIOSCIENCE CORP. Depletion
LEXARIA BIOSCIENCE CORP. (LEXX) reported Depletion of $0 for the 12-month period ending 2015-08-31, per its 10-K filed 2015-11-27.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:Depletion · last filed 2015-11-27
- LEXARIA BIOSCIENCE CORP. depletion for the quarter ending 2015-08-31 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. depletion for the quarter ending 2014-11-30 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. depletion for the quarter ending 2014-08-31 was $43.40K.
- LEXARIA BIOSCIENCE CORP. depletion for the quarter ending 2013-11-30 was $200.75K.
- LEXARIA BIOSCIENCE CORP. depletion for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- LEXARIA BIOSCIENCE CORP. depletion for fiscal 2014 was $161.11K.
| Period end | Depletion 3 month | Depletion 6 month | Depletion 9 month | Depletion 12 month |
|---|---|---|---|---|
| 2015-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-27 | $0.00 10-K · filed 2015-11-27 | ||
| 2015-05-31 | $0.00 10-Q · filed 2015-07-14 | |||
| 2015-02-28 | $0.00 10-Q · filed 2015-04-14 | |||
| 2014-11-30 | $0.00 10-Q · filed 2015-01-14 | $43.40K derived: sum of 2 quarters · filed 2015-11-27 | ||
| 2014-08-31 | $43.40K derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-27 | $161.11K 10-K · filed 2015-11-27 | ||
| 2014-05-31 | $117.72K 10-Q · filed 2015-07-14 | |||
| 2014-02-28 | $117.72K 10-Q · filed 2015-04-14 | |||
| 2013-11-30 | $200.75K 10-Q · filed 2015-01-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |